User profiles for Rachel A. Bender Ignacio
Rachel Bender IgnacioAllergy and Infectious Diseases, University of Washington Verified email at uw.edu Cited by 675 |
Drug combinations as a first line of defense against coronaviruses and other emerging viruses
The world was unprepared for coronavirus disease 2019 (COVID-19) and remains ill-equipped
for future pandemics. While unprecedented strides have been made developing …
for future pandemics. While unprecedented strides have been made developing …
Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy
…, T Stevens-Ayers, RA Bender Ignacio… - Blood …, 2019 - ashpublications.org
The long-term effects of CD19-targeted chimeric antigen receptor–modified T-cell
immunotherapy (CD19-CARTx) for B-cell malignancies on humoral immunity are unclear. We …
immunotherapy (CD19-CARTx) for B-cell malignancies on humoral immunity are unclear. We …
[PDF][PDF] Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure
RAB Ignacio, S Dasgupta, R Valdez, U Pandey… - Iscience, 2022 - cell.com
Prior studies attempting to link biomarkers of immune activation with risk of acquiring HIV have
relied on cross sectional samples, most without proximity to HIV acquisition. We created a …
relied on cross sectional samples, most without proximity to HIV acquisition. We created a …
[HTML][HTML] Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study
M Massanella, RAB Ignacio, JR Lama… - The Lancet …, 2021 - thelancet.com
Background Early antiretroviral therapy (ART) initiation (ie, within 3 months of infection) limits
establishment of the HIV reservoir. However, the effect of early ART initiation on the long-…
establishment of the HIV reservoir. However, the effect of early ART initiation on the long-…
Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.
AE Shapiro, RAB Ignacio, BM Whitney… - JAIDS Journal of …, 2022 - journals.lww.com
Background: Understanding the spectrum of COVID-19 in people with HIV (PWH) is critical
to provide clinical guidance and risk-reduction strategies. Setting: CNICS, a US multisite …
to provide clinical guidance and risk-reduction strategies. Setting: CNICS, a US multisite …
Comparative pharmacokinetics of tixagevimab/cilgavimab (AZD7442) administered intravenously versus intramuscularly in symptomatic SARS‐CoV‐2 infection
RA Bender Ignacio, DA Wohl, R Arends… - Clinical …, 2022 - Wiley Online Library
AZD7442 (Evusheld) is a combination of two human anti‐severe acute respiratory syndrome‐coronavirus
2 (SARS‐CoV‐2) monoclonal antibodies (mAbs), tixagevimab (AZD8895) and …
2 (SARS‐CoV‐2) monoclonal antibodies (mAbs), tixagevimab (AZD8895) and …
Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation
RA Bender Ignacio, S Dasgupta… - Blood, The Journal …, 2019 - ashpublications.org
Further insight into humoral viral immunity after hematopoietic cell transplantation (HCT) could
have potential impact on donor selection or monitoring of patients. Currently, estimation of …
have potential impact on donor selection or monitoring of patients. Currently, estimation of …
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis
We investigated whether countries with higher coverage of childhood live vaccines [BCG or
measles-containing-vaccine (MCV)] have reduced risk of coronavirus disease 2019 (COVID-…
measles-containing-vaccine (MCV)] have reduced risk of coronavirus disease 2019 (COVID-…
HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru
…, J Mullins, RA Bender Ignacio - Journal of the …, 2019 - Wiley Online Library
Introduction Transmitted, or any pretreatment drug resistance (TDR, PDR) can compromise
efficacy of first‐line antiretroviral therapy (ART). In Peru, genotypic resistance testing is not …
efficacy of first‐line antiretroviral therapy (ART). In Peru, genotypic resistance testing is not …
Safety and efficacy of combined tixagevimab and cilgavimab administered intramuscularly or intravenously in nonhospitalized patients with COVID-19: 2 randomized …
RAB Ignacio, KW Chew, C Moser, JS Currier… - JAMA Network …, 2023 - jamanetwork.com
… Drs Bender Ignacio and Chew contributed equally as co–first authors. Drs Smith and Wohl
… Conflict of Interest Disclosures: Dr Bender Ignacio reported consulting for AbbVie Inc and …
… Conflict of Interest Disclosures: Dr Bender Ignacio reported consulting for AbbVie Inc and …